Transfer of the Patent on "Therapeutic Agents for SARS-CoV-2 Infection"

[24.03.27]

Based on the results of joint research between the Division of Infection Control Research, Center for Advanced Science Research and Promotion, Kagoshima University and Professor Shin Aoki at the Faculty of Pharmaceutical Sciences, Tokyo University of Science, both universities have applied to the Japan Science and Technology Agency (JST) for support in transferring the patent related to "Therapeutic Agents for SARS-CoV-2 Infection" to foreign countries. We have recently received the notification from JST that they have decided to support the transfer of the patent to the United States. In response to this decision, Kagoshima University and Tokyo University of Science will proceed with the transfer of the patent to Japan, China, and Europe in addition to the United States, and will explore the possibility of joint development research with pharmaceutical companies that are interested in this invention.

<Related links>
Center for Advanced Science Research and Promotion Division of Infection Control Research
Tokyo University of Science